News | November 17, 2025
AstraZeneca and Sun Pharma partner to expand hyperkalemia treatment in India
Both companies will promote, market and distribute Sodium Zirconium Cyclosilicate in India under different brand names
Both companies will promote, market and distribute Sodium Zirconium Cyclosilicate in India under different brand names
Uncontrolled diabetes in pregnancy dramatically increases the risk of pre-eclampsia, stillbirth, birth injuries, and long-term cardiometabolic diseases
The new formulation features what Abbott calls a “triple care system,” anchored by a blend of nutrients aimed at supporting blood sugar control and metabolic health
Dexlansoprazole delayed-release capsules are a proton pump inhibitor
The FDA is initiating removal of the boxed warnings following a comprehensive review of the scientific literature
Nearly 1 in 3 HbA1c test results fall within the diabetic range, while 1 in 4 individuals show signs of prediabetes
Patients on baxdrostat showed a significant reduction in systolic blood pressure (SBP) compared to placebo
The device delivers clear, high-quality images to support accurate diagnoses across a broad range of patient groups
The study demonstrated strong clinical outcomes, with 94.8 per cent of subjects remaining free from major target limb amputation at one year
The company has introduced an innovative Dual Release Proton Pump Inhibitor (PPI) tablet, a next-generation therapy for patients suffering from moderate to severe or treatment resistant gastroesophageal reflux disease
Subscribe To Our Newsletter & Stay Updated
